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of pan-resistant Acinetobacter spp or carbapenem-resistant
Klebsiella spp (e.g. roommates of newly identiﬁed carriers)
and apply speciﬁc preventive measures (contact isolation)
applied to identiﬁed carriers, especially in the critical
care setting. Second, eradicating carriage of multi-resistant
bacteria may reduce the rates of infection. However, no con-
trolled studies are available indicating that this approach
may work. Third, strict compliance with standard pre-
cautions and hand hygiene could prevent most cases of
cross-transmission, even without the need for recognition
of individual carriers of resistant microorganisms. Unfor-
tunately, many studies have shown that compliance of
healthcare workers with hand hygiene recommendations
remains low. Implementing alcohol-based hand rinses can
improve compliance and decrease cross-infection. Finally,
antibiotic selection pressure contributes to the increase in
prevalence of multi-resistant Gram-negative bacteria. Data
from several recently published studies suggest that restric-
tion of certain classes of antibiotics may decrease rates
of multi-resistant Gram-negative bacteria in the hospital
setting. Other well-designed investigations are needed to
conﬁrm that reduction in antimicrobial overuse has a favor-
able effect on infection rates caused by multi-resistant
Gram-negative bacteria.
doi:10.1016/j.ijid.2008.05.062
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Burden of Pertussis Worldwide: Strategies to Reinforce
Pertussis Control in Children, Adolescents, and Adults
K. Forsyth
Flinders Medical Centre and Flinders University, Adelaide,
Australia
Pertussis disease is a signiﬁcant cause of morbidity and
mortality amongst the unimmunised or insufﬁciently immu-
nised. Data on pertussis disease trends will be presented.
As for solutions, in spite of immunisation campaigns tar-
geted at parents of infants and children, there are still
major problems with. Strategies to reduce the burden of
pertussis disease include; universal adult immunisation,
selective immunisation of mothers and close family contacts
of newborns, selectiveimmunisation of health care work-
ers, selective immunisation of child care workers, universal
immunisation of adolescents, pre-school boosters at 4—6
years of. No single strategy is likely to be appropriate for
all. Data on pertussis disease and discussion around these
public health policy issues for the prevention of pertussis
will be discussed.
doi:10.1016/j.ijid.2008.05.063
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n the prevaccine era, pertussis was one of the most com-
on childhood bacterial infections with more than half of
hildren becoming infected before school age. The disease
as one of the leading causes of infant death in the 19th
entury.
The introduction of whole-cell pertussis vaccine in
he 1940s and its subsequent widespread use globally
as resulted in a reduction in the incidence, morbidity
nd mortality of this disease. The whole-cell pertussis
accine was nevertheless associated with frequent local
nd systemic adverse reactions, occasionally some that
ere more severe such as febrile seizures or hypotonic-
yporesponsive episodes. The shift, in the 1990s, from
hole-cell pertussis vaccine to less reactogenic acellular
ertussis vaccine was associated with signiﬁcantly reduced
ates of vaccine-associated adverse events. In recent years,
cellular pertussis vaccine has been incorporated into
he immunization schedules of many developed countries,
radually replacing whole-cell pertussis vaccine. Dosing
chedules vary between countries. As it has become appar-
nt that the epidemiology of pertussis is gradually shifting
o the adolescent and adult age groups, many countries are
ugmenting their program of immunization by having intro-
uced, or are planning to introduce, an acellular pertussis
accine booster dose for use in children 6 years of age or in
he adolescent age group.
The use of combination vaccines with inclusion of acel-
ular pertussis vaccine in many countries has been proven
o be efﬁcacious and prevents children from undergoing an
xcessive number of injections. The individual components
ncluded in these combination vaccines can be adjusted
ccording to differences in the burden of disease in different
ountries.
oi:10.1016/j.ijid.2008.05.064
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Sanoﬁ Pasteur, USA
n most developed countries, long-standing vaccination
rograms for infants and young children have led to substan-
ial decreases in pertussis disease since their introduction
n the 1940s. More recently, however, there has been a
esurgence of pertussis case reports, most notably among
dolescents and adults. Immunity from childhood pertus-
is vaccinations wanes after several years, but natural
oosting through repeated subclinical infection is now
ncommon; most adolescents and adults are again suscep-
ible to pertussis. Manifestations of pertussis in these age
roups are highly variable, ranging from mild symptoms
nlikely to prompt medical care through typical whoop-
ng cough. Complications are common and include sleep
